Clinical Studies with the Potassium Channel Activator Cromakalim in Normotensive and Hypertensive Subjects

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  1990-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00005344-199011000-00015PMID 1703602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Controlled comparison of the pharmacodynamic effects of nicorandil (SG-75) and isosorbide dinitrate in man

  2004cited by this paper
• The combination of prazosin and verapamil in the treatment of essential hypertension

  1988cited by this paper
• Nifedipine: Individual Responses and Concentration‐Effect Relationships

  1988cited by this paper
• Mechanism of Action and Systemic and Regional Hemodynamics of the Potassium Channel Activator BRL34915 and Its Enantiomers

  1988cited by this paper
• Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease

  1988cited by this paper
• The Haemodynamic Profile of Cromakalim in the Cat

  1988cited by this paper
• Nicardipine

  1987cited by this paper
• Acute haemodynamic effects of pinacidil in man.

  1986cited by this paper
• Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein

  1986cited by this paper
• BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models.

  1986cited by this paper
• The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels

  1986cited by this paper
• Mechanism by which hydralazine increases propranolol bioavailability

  1984cited by this paper
• Analysis of the pressor dose response

  1982cited by this paper
• Atenolol determination by high-performance liquid chromatography and fluorescence detection.

  1979cited by this paper
• Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range.

  1976cited by this paper
• Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity.

  1974cited by this paper
• A Computerized Cumulative Integral Method for the Precise Measurement of the Glomerular Filtration Rate 1

  1972cited by this paper
• The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

  1961cited by this paper

• Selective Optimization of Side Activities (SOSA): A Promising way for Drug Discovery

  2012cites this paper
• Sarcolemmal KATP channel modulators and cardiac arrhythmias.

  2011cites this paper
• DRUG RESEARCH AND DEVELOPMENT - CASE SCENARIOS, DEVELOPMENT PROCESS, RISKS AND BENEFITS

  2011cites this paper
• channel therapeutics at the bedside

  2009cites this paper
• Effect of nicorandil on proteinuria in well controlled hypertensive patients

  2009cites this paper
• K(ATP) channel therapeutics at the bedside.

  2005cites this paper
• Focused issue on KATP channels K ATP channel therapeutics at the bedside

  2005cites this paper
• Effects of ATP‐sensitive K+ channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstruction

  2003cites this paper
• Potassium channel openers: therapeutic potential in cardiology and medicine

  2001cites this paper
• Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Potassium Channel Opener, SKP‐450, in Healthy Volunteers

  2000cites this paper
• Effects of ZD6169, a K(ATP) channel opener, on the micturition reflex in the rat.

  1999cites this paper
• Effects of ZD 6169 , a KATP Channel Opener , on the Micturition Reflex in the Rat 1

  1999cites this paper
• Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure: a comparison with cromakalim and nitroglycerin.

  1999cites this paper
• Effects of ZD6169, a KATP channel opener, on bladder hyperactivity and spinal c-fos expression evoked by bladder irritation in rats.

  1998cites this paper
• Potassium Channels in Neuropsychiatric Disorders

  1998cites this paper
• Impaired action of levcromakalim on ATP-sensitive K+ channels in mesenteric artery cells from spontaneously hypertensive rats.

  1996cites this paper
• Relaxant effect of levcromakalim in isolated human small subcutaneous arteries.

  1995cites this paper
• Cardiovascular Profile of RWJ 29009, a New Potassium Channel Activator, in Anesthetized and Conscious Dogs

  1994cites this paper
• Pulmonary hydraulic impedance response to cromakalim (BRL 34915) in newborn pigs.

  1994cites this paper
• Therapeutic potential of potassium channel activators in coronary heart disease.

  1994cites this paper
• Vasodilator action of cromakalim on human mesenteric artery.

  1993cites this paper
• Cardiotoxicity of vasodilators and positive inotropic/vasodilating drugs in dogs: an overview.

  1992cites this paper
• Cardiovascular effects of the novel potassium channel opener (3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxo- 1-pyrrolidinyl)-6-phenylsulfonylchromane hemihydrate.

  1992cites this paper
• Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.

  1992cites this paper
• Clinical pharmacology of potassium channel openers.

  1992cites this paper
• Electromechanical effects of the putative potassium channel activator celikalim (WAY-120,491) on feline atrial and ventricular muscle.

  1992cites this paper